|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,830,000 |
Market
Cap: |
3.78(B) |
Last
Volume: |
581,366 |
Avg
Vol: |
694,871 |
52
Week Range: |
$39.75 - $67.51 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Semiconductor Equipment & Materials |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ COMPUTER |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 443 |
Guru Rank Value : 3.1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Azenta provides life science sample exploration and management solutions. Co.'s segments are: Life Sciences Products, which provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments; and Life Sciences Services, which provides sample management programs, cold chain solutions, informatics, as well as sample-based laboratory services, including sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services to scientific research and support drug development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
12,975 |
Total Buy Value |
$0 |
$0 |
$0 |
$752,191 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
39,197 |
39,197 |
Total Sell Value |
$0 |
$0 |
$2,183,306 |
$2,183,306 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
5 |
5 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Allen A Clinton |
Director |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,355 |
72,348 |
|
- |
|
Woollacott Alfred III |
Director |
|
2017-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,355 |
81,493 |
|
- |
|
Joseph Jason |
VP, General Counsel, Secretary |
|
2017-02-02 |
4 |
AS |
$19.58 |
$163,493 |
D/D |
(8,350) |
123,031 |
|
- |
|
Montone William T. |
SVP, Human Resources |
|
2017-02-02 |
4 |
AS |
$19.33 |
$289,950 |
D/D |
(15,000) |
136,756 |
|
- |
|
Joseph Jason |
VP, General Counsel, Secretary |
|
2017-01-13 |
4 |
AS |
$17.50 |
$85,470 |
D/D |
(4,884) |
129,918 |
|
- |
|
Montone William T. |
SVP, Human Resources |
|
2017-01-12 |
4 |
AS |
$17.09 |
$213,566 |
D/D |
(12,500) |
151,756 |
|
- |
|
Allen A Clinton |
Director |
|
2017-01-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
200 |
67,993 |
|
- |
|
Joseph Jason |
VP, General Counsel, Secretary |
|
2017-01-04 |
4 |
AS |
$16.77 |
$138,453 |
D/D |
(8,256) |
134,802 |
|
- |
|
Allen A Clinton |
Director |
|
2016-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
68,193 |
|
- |
|
Pietrantoni David |
Principal Accounting Officer |
|
2016-12-07 |
4 |
S |
$16.59 |
$199,080 |
D/D |
(12,000) |
71,336 |
|
- |
|
Tenney Maurice H. |
President-Brooks Life Sciences |
|
2016-12-07 |
4 |
S |
$16.52 |
$82,600 |
D/D |
(5,000) |
198,795 |
|
- |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2016-12-06 |
4 |
S |
$16.20 |
$354,861 |
D/D |
(21,905) |
224,943 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2016-11-28 |
4 |
AS |
$16.67 |
$166,700 |
D/D |
(10,000) |
654,339 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2016-11-23 |
4 |
S |
$16.45 |
$164,500 |
D/D |
(10,000) |
103,111 |
|
- |
|
Woollacott Alfred III |
Director |
|
2016-11-22 |
4 |
S |
$16.41 |
$164,100 |
D/D |
(10,000) |
77,138 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2016-11-21 |
4 |
AS |
$15.81 |
$158,100 |
D/D |
(10,000) |
664,339 |
|
- |
|
Tenney Maurice H. |
President-Brooks Life Sciences |
|
2016-11-16 |
4 |
S |
$15.35 |
$232,046 |
D/D |
(15,117) |
203,795 |
|
- |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2016-11-16 |
4 |
S |
$15.35 |
$449,248 |
D/D |
(29,267) |
246,848 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2016-11-16 |
4 |
S |
$15.35 |
$972,407 |
D/D |
(63,349) |
605,286 |
|
- |
|
Pietrantoni David |
Principal Accounting Officer |
|
2016-11-16 |
4 |
S |
$15.35 |
$104,242 |
D/D |
(6,791) |
83,336 |
|
- |
|
Joseph Jason |
VP, General Counsel, Secretary |
|
2016-11-16 |
4 |
S |
$15.35 |
$186,134 |
D/D |
(12,126) |
143,058 |
|
- |
|
Jarzynka David |
Sr. VP, General Manager |
|
2016-11-16 |
4 |
S |
$15.35 |
$196,802 |
D/D |
(12,821) |
39,129 |
|
- |
|
Montone William T. |
SVP, Human Resources |
|
2016-11-16 |
4 |
S |
$15.35 |
$186,134 |
D/D |
(12,126) |
164,256 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2016-11-16 |
4 |
S |
$15.35 |
$239,046 |
D/D |
(15,573) |
113,111 |
|
- |
|
Davis Robyn C |
Director |
|
2016-11-15 |
4 |
S |
$15.51 |
$46,530 |
D/D |
(3,000) |
3,569 |
|
- |
|
1054 Records found
|
|
Page 18 of 43 |
|
|